BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19781330)

  • 1. Uncommon characteristics of the structure and development of Trichosporon asahii.
    Wang WL; Yang RY; Ao JH
    Chin Med J (Engl); 2009 Aug; 122(15):1806-10. PubMed ID: 19781330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifungal effect of silver nanoparticles on Trichosporon asahii.
    Xia ZK; Ma QH; Li SY; Zhang DQ; Cong L; Tian YL; Yang RY
    J Microbiol Immunol Infect; 2016 Apr; 49(2):182-8. PubMed ID: 24877597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
    Di Bonaventura G; Pompilio A; Picciani C; Iezzi M; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated, fatal Trichosporon asahii infection in a bone marrow transplant recipient.
    Ghiasian SA; Maghsood AH; Mirhendi SH
    J Microbiol Immunol Infect; 2006 Oct; 39(5):426-9. PubMed ID: 17066207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of arthroconidia in biofilm formation by Trichosporon asahii.
    Kurakado S; Miyashita T; Chiba R; Sato C; Matsumoto Y; Sugita T
    Mycoses; 2021 Jan; 64(1):42-47. PubMed ID: 32918326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
    Yang RY; Wang WL; Ao JH; Hao ZF; Zhang J; Wang CM
    Chin Med J (Engl); 2008 Dec; 121(24):2557-60. PubMed ID: 19187595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of IGS1, ITS and D1/D2 regions in molecular identification of Trichosporon species and genotype of T. asahii in China].
    Xia ZK; Yang RY; Wang WL; Ao JH; Wang CM; Zhu H
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3145-8. PubMed ID: 19159600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY; Chien JY; Hsueh PR
    Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of some virulence factors in Trichosporon spp. strains].
    Demir F; Kuştimur S
    Mikrobiyol Bul; 2014 Oct; 48(4):628-38. PubMed ID: 25492658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichosporon asahii as an emerging etiologic agent of disseminated trichosporonosis: a case report and an update.
    Chowdhary A; Ahmad S; Khan ZU; Doval DC; Randhawa HS
    Indian J Med Microbiol; 2004; 22(1):16-22. PubMed ID: 17642680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Trichosporon asahii spondylodiscitis after open lumbar discectomy: a case report.
    Kim KW; Ha KY; Kim MS; Choi SM; Lee JS
    Spine (Phila Pa 1976); 2008 Feb; 33(4):E116-20. PubMed ID: 18277860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching of colony morphology and adhesion activity of Trichosporon asahii clinical isolates.
    Ichikawa T; Yoshiyama N; Ohgane Y; Ikeda R
    Med Mycol; 2016 Feb; 54(2):189-96. PubMed ID: 26483434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of the emerging human pathogens Trichosporon asahii and Trichosporon asteroides from other pathogenic yeasts and moulds by using species-specific monoclonal antibodies.
    Davies GE; Thornton CR
    PLoS One; 2014; 9(1):e84789. PubMed ID: 24392156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichosporon asahii secretes a 30-kDa aspartic peptidase.
    Valle RS; Ramos LS; Reis VJ; Ziccardi M; Dornelas-Ribeiro M; Sodré CL; Branquinha MH; Santos ALS
    Microbiol Res; 2017 Dec; 205():66-72. PubMed ID: 28942846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin.
    Cordeiro RA; Pereira LMG; de Sousa JK; Serpa R; Andrade ARC; Portela FVM; Evangelista AJJ; Sales JA; Aguiar ALR; Mendes PBL; Brilhante RSN; Sidrim JJDC; Castelo-Branco DSCM; Rocha MFG
    Med Mycol; 2019 Nov; 57(8):1038-1045. PubMed ID: 30649480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic switching and beta-N-acetylhexosaminidase activity of the pathogenic yeast Trichosporon asahii.
    Ichikawa T; Sugita T; Wang L; Yokoyama K; Nishimura K; Nishikawa A
    Microbiol Immunol; 2004; 48(4):237-42. PubMed ID: 15107533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth Inhibition of an Opportunistic Yeast Pathogen Trichosporon asahii by Staphylococcus epidermidis.
    Ikeda R; Ogasawara Y; Takatori K; Ichikawa T; Nakajima M; Harigaya K; Watanabe M; Okudaira E; Yoshikawa H; Yanagisawa K
    Biol Pharm Bull; 2017; 40(5):693-697. PubMed ID: 28458355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous abscess by Trichosporon asahii developing on a steroid injection site in a healthy adult.
    Yun SJ; Lee JB; Shin MG; Kim SJ; Won YH; Lee SC
    Clin Exp Dermatol; 2006 Jul; 31(4):545-7. PubMed ID: 16716160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Ethanol against Trichosporon asahii Biofilm in vitro.
    Liao Y; Zhao H; Lu X; Yang S; Zhou J; Yang R
    Med Mycol; 2015 May; 53(4):396-404. PubMed ID: 25851264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Trichosporon asahii infection in a preterm.
    Yildiran A; Kücüködük S; Saniç A; Belet N; Güvenli A
    Am J Perinatol; 2003 Jul; 20(5):269-71. PubMed ID: 13680511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.